Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Procalcitonin Point-of-care Test to Guide De-escalation of Empiric Antibiotic Therapy in Adult Patients With Sepsis in a Tertiary Hospital in Bangladesh (PROCALBAN): a Phase 3 Randomised, Controlled, Open-label Trial

NCT05955612 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05955612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05955612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Procalcitonin Point-of-care Test to Guide De-escalation of Empiric Antibiotic Therapy in Adult Patients With Sepsis in a Tertiary Hospital in Bangladesh (PROCALBAN): a Phase 3 Randomised, Controlled, Open-label Trial
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Completed
Start date
July 26, 2023
Completion date
July 30, 2024
Enrollment
532 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis